CCK-antagonists in a rat exposed to acute stress: implication for anxiety associated with post-traumatic stress disorder.
Cohen
H
H
Ministry of Health Mental Health Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. hagitc@bgumail.bgu.ac.il
Kaplan
Z
Z
Kotler
M
M
D000818:Animals; D014151:Anti-Anxiety Agents / Q000008:administration & dosage*; D001007:Anxiety / Q000209:etiology / Q000378:metabolism*; D001522:Behavior, Animal / Q000187:drug effects; D001549:Benzamides / Q000008:administration & dosage; D002766:Cholecystokinin / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D007211:Indoles / Q000008:administration & dosage; D008297:Male; D018782:Maze Learning / Q000187:drug effects*; D008536:Meglumine / Q000008:administration & dosage / Q000031:analogs & derivatives; D009812:Odorants; D011377:Proglumide / Q000008:administration & dosage; D051381:Rats; D017208:Rats, Wistar; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors; D013313:Stress Disorders, Post-Traumatic / Q000150:complications / Q000378:metabolism*; D013315:Stress, Psychological / Q000378:metabolism*
D014151:Anti-Anxiety Agents; D001549:Benzamides; D007211:Indoles; D011949:Receptors, Cholecystokinin; C065600:PD 135158; D008536:Meglumine; D002766:Cholecystokinin; D011377:Proglumide; C013841:benzotript